首页> AIDS (London, England)> Is nelfinavir exposure associated with cancer incidence in HIV-positive individuals?

Is nelfinavir exposure associated with cancer incidence in HIV-positive individuals?

导出 OA

翻译打印收藏纠错

第一作者： David C,Boettiger

第一单位： aThe Kirby Institute, UNSW Australia, Sydney, AustraliabResearch Department of Infection and Population Health, UCL, London, United KingdomcCHIP, Department of Infectious Diseases, Section 2100, Rigshospitalet - University of Copenhagen, Copenhagen, DenmarkdCHU de Bordeaux and INSERM U897, Université de Bordeaux, Talence, FranceeDivision of Infectious Diseases and Department of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam, NetherlandsfDepartment of Health Sciences, San Paolo University Hospital, Milan, ItalygNational Centre for HIV Malignancy, Chelsea & Westminster Hospital, London, United KingdomhDepartment of Internal Medicine I, University Hospital of Cologne, Cologne, Germany.

作者： David C,Boettiger ^[1] ; Caroline A,Sabin ; Andrew,Grulich ; Lene,Ryom ; Fabrice,Bonnet ; Peter,Reiss ; Antonella d'arminio,Monforte ; Ole,Kirk ; Andrew,Phillips ; Mark,Bower ; Gerd,Fätkenheuer ; Jens D,Lundgren ; Matthew,Law ; Data collection on Adverse events of Anti-HIV Drugs (D:A:D) study group

作者单位： aThe Kirby Institute, UNSW Australia, Sydney, AustraliabResearch Department of Infection and Population Health, UCL, London, United KingdomcCHIP, Department of Infectious Diseases, Section 2100, Rigshospitalet - University of Copenhagen, Copenhagen, DenmarkdCHU de Bordeaux and INSERM U897, Université de Bordeaux, Talence, FranceeDivision of Infectious Diseases and Department of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam, NetherlandsfDepartment of Health Sciences, San Paolo University Hospital, Milan, ItalygNational Centre for HIV Malignancy, Chelsea & Westminster Hospital, London, United KingdomhDepartment of Internal Medicine I, University Hospital of Cologne, Cologne, Germany. ^[1]